Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) FCF Margin (2016 - 2026)

OptimizeRx's FCF Margin history spans 16 years, with the latest figure at 22.09% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 2109.0% to 22.09% in Q4 2025 year-over-year; TTM through Dec 2025 was 17.05%, a 1186.0% increase, with the full-year FY2025 number at 17.05%, up 1186.0% from a year prior.
  • FCF Margin hit 22.09% in Q4 2025 for OptimizeRx, up from 12.08% in the prior quarter.
  • Over the last five years, FCF Margin for OPRX hit a ceiling of 29.61% in Q1 2022 and a floor of 24.53% in Q4 2023.
  • Historically, FCF Margin has averaged 6.68% across 5 years, with a median of 8.44% in 2024.
  • Biggest five-year swings in FCF Margin: surged 6416bps in 2021 and later crashed -3829bps in 2023.
  • Tracing OPRX's FCF Margin over 5 years: stood at 8.05% in 2021, then skyrocketed by 271bps to 13.76% in 2022, then crashed by -278bps to 24.53% in 2023, then surged by 104bps to 0.99% in 2024, then skyrocketed by 2124bps to 22.09% in 2025.
  • Business Quant data shows FCF Margin for OPRX at 22.09% in Q4 2025, 12.08% in Q3 2025, and 15.59% in Q2 2025.